China Clinical Nutrition Market to grow at 9% CAGR from 2017 to 2024 - PowerPoint PPT Presentation

Loading...

PPT – China Clinical Nutrition Market to grow at 9% CAGR from 2017 to 2024 PowerPoint presentation | free to download - id: 869169-ZmQ5Z



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

China Clinical Nutrition Market to grow at 9% CAGR from 2017 to 2024

Description:

Get more details @ Few players dominate clinical nutrition market such as Abbott Laboratories, Nestle, Danone, Fresenius Kabi, Hospira, Perrigo, B Braun Melsungen, Baxter International and Mead Johnson. Product development, strategic alliances and consolidating across the distribution channel remain key commercial strategies adopted by industry participants. Industry participants are also expanding their operations in emerging economies to gain extended market access and strengthen their market position. – PowerPoint PPT presentation

Number of Views:12

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: China Clinical Nutrition Market to grow at 9% CAGR from 2017 to 2024


1
Infant applications of Clinical Nutrition Market
to grow at 9 CAGR from 2017 to 2024 Global
Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Clinical Nutrition Market
  • Rising global population, escalating burden of
    chronic diseases, increasing number of pre-mature
    deaths and growing inclination towards home
    healthcare will drive global clinical nutrition
    market size. Malnutrition is the leading cause of
    child deaths in most developing countries.
  • Rising metabolic disorders has become a growing
    public health concern worldwide. Increasing
    instances of malnutrition coupled with high
    metabolic disorder prevalence will stimulate
    growth.
  • Rapid advances in clinical nutrition design and
    composition coupled with continuous quality
    improvement initiatives should expand industry
    size. Availability of nutritional practice
    guidelines should improve the delivery of patient
    nutrition care.
  • Stringent government regulations, lack of uniform
    reimbursement policies worldwide, market
    volatility and complexities in patient compliance
    will deter clinical nutrition market growth.

3
Continued...
  • Enteral nutrition should witness over 5 CAGR
    with expectations to surpass USD 20 billion by
    2024. Increasing preference for enteral route of
    food administration coupled with technological
    innovation for development of novel enteral
    feeding devices should contribute towards segment
    growth.
  • Favorable government initiatives in delivering
    nutrition services and wide application of
    clinical nutrition in food industry,
    pharmaceutical and home healthcare should
    accelerate business growth. Some of the European
    countries have launched Fight Against
    Malnutrition (FAM) program to curb the spread of
    malnutrition.
  • APAC accounted for more than 40 industry share,
    followed by Europe and North America. The
    regional nutrition market should surpass USD 30
    billion by 2024, with infant nutrition holding
    the significant business share.
  • Infant applications held more than 50 of
    clinical nutrition market share and is
    anticipated to witness more than 9 CAGR over the
    forecast years.

4
Europe Clinical Nutrition Market, By Product,
2012 - 2024 (USD Million)

5
Browse Full Market Research Report On Clinical
Nutrition Market _at_ http//bit.ly/2oBHLF0
Request for a Sample of this Research
Report _at_ https//www.gminsights.com/request-sample
/detail/1324 https//www.gminsights.com/request-s
ample/detail/49
6
Continued...
  • The milk based products should experience a
    considerable growth owing to improved tolerance
    and good taste, thus surpassing the market value
    of over USD 35 billion by 2024.
  • Parenteral nutrition should witness a
    considerable growth to reach USD 7 billion. Amino
    acids held more than 40 parenteral nutrition
    share as they are essential to achieve balanced
    body metabolism. Fats will witness a robust
    growth of over 6.
  • UK held over 17 of Europe clinical nutrition
    market share owing to the rising healthcare
    spending across the region.
  • Few players dominate clinical nutrition market
    such as Abbott Laboratories, Nestle, Danone,
    Fresenius Kabi, Hospira, Perrigo, B Braun
    Melsungen, Baxter International and Mead Johnson.
    Product development, strategic alliances and
    consolidating across the distribution channel
    remain key commercial strategies adopted by
    industry participants.

7
Stay In Touch Website www.gminsights.com Soci
al Media
About PowerShow.com